Detalles de la búsqueda
1.
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 21(16): 3586-90, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275952
2.
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.
Clin Cancer Res
; 18(21): 5845-9, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22962441
Resultados
1 -
2
de 2
1
Próxima >
>>